İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 92
YÖKSİS92 OpenAlex0
Proje 0
Kitap 11
Bildiri 140

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 11
h-indeks 5 Türkiye yüzdelik dilimi: 66 Üniversitesinde h-indekse göre 406. / 1.484
i10-indeks
2
Toplam atıf
70
Türkiye’de üst %38
Makale başına
6,4
FWCI
1,33
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
2

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 80
  • Q1 27
  • Q2 26
  • Q3 22
  • Q4 5
WoS (JCR) 80
  • Q1 23
  • Q2 15
  • Q3 21
  • Q4 21
TR Index TR Index

19 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 2
  • Ort. 74.7%
  • n 9
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 79 Q1 26 Q2 26 Q3 22 Q4 5
  • YÖKSİS satırı 80

WoS (JCR)

  • Özet hariç 79 Q1 22 Q2 15 Q3 21 Q4 21
  • YÖKSİS satırı 80

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

53 dergi

Makale listesi

  1. 2025 Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry Rheumatology DOI 10.1093/rheumatology/keaf181 YÖKSİS SJR Q1 JCR Q1
  2. 2025 Development and implementation of the international AIDA network spondylarthritis registry Frontiers in Medicine DOI 10.3389/fmed.2025.1509357 YÖKSİS SJR Q1 JCR Q1 OpenAlex 63.6%
  3. 2025 Lupus and IgA nephropathy: coexistence or coincident? Wiener klinische Wochenschrift DOI 10.1007/s00508-025-02512-y YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.0%
  4. 2025 Evaluation of treatment compliance in gout patients: a patient-centered study Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.5985 YÖKSİS TR Index SJR Q3 JCR Q2
  5. 2025 The evaluation of myocarditis in patients with Still's disease; clinical findings from the multicentre international AIDA Network Still's Disease Registry J Rheumatol DOI 10.3899/jrheum.2024-0683 YÖKSİS SJR Q2 JCR Q2
  6. 2025 Development and implementation of the International AIDA Network Castleman’s disease registry Frontiers in Medicine DOI 10.3389/fmed.2025.1579182 YÖKSİS SJR Q1 JCR Q1
  7. 2025 A new characteristic of SLE: subclinical vein involvement–an in-depth biochemical and imaging study Rheumatology DOI 10.1093/rheumatology/keaf468 YÖKSİS SJR Q1 JCR Q1 OpenAlex 75.2%
  8. 2025 Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography Academic Radiology DOI 10.1016/j.acra.2025.02.032 YÖKSİS SJR Q1 JCR Q1
  9. 2025 Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus Lupus DOI 10.1177/09612033251319405 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.4%
  10. 2025 Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry Frontiers in Pharmacology DOI 10.3389/fphar.2025.1462254 YÖKSİS SJR Q1 JCR Q1
  11. 2025 Evolution of Clinical Characteristics and Treatment Strategies in Turkish SLE Patients Over Two Decades: A Retrospective Cohort Study Bratislava Medical Journal DOI 10.1007/s44411-025-00226-1 YÖKSİS SJR Q3 JCR Q2
  12. 2025 Importance of potential prothrombotic state markers in Behçet’s disease and correlation with vascular ultrasound Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-03972-x YÖKSİS SJR Q2 JCR Q2
  13. 2025 POS0583 IL-40: A NOVEL PROINFLAMMATORY B CELL-ASSOCIATED CYTOKINE AND ITS ROLE IN SYSTEMIC SCLEROSIS Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.05.965 YÖKSİS SJR Q1 JCR Q1
  14. 2025 Is IgG4‐Related Disease a Potential Risk Factor for Multiple Malignancies? International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.70286 YÖKSİS SJR Q3 JCR Q3
  15. 2025 PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD Biomarkers in Medicine DOI 10.1080/17520363.2025.2485014 YÖKSİS SJR Q2 JCR Q3
  16. 2024 Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.15175 YÖKSİS SJR Q3 JCR Q3
  17. 2024 Influence of gender on Behçets disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçets Disease Registry Joint Bone Spine DOI 10.1016/j.jbspin.2024.105819 YÖKSİS SJR Q2 JCR Q1
  18. 2024 Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS) Internal and Emergency Medicine DOI 10.1007/s11739-024-03577-9 YÖKSİS SJR Q1 JCR Q1
  19. 2024 Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye Archives of Rheumatology DOI 10.46497/ArchRheumatol.2024.10268 YÖKSİS SJR Q3 JCR Q4
  20. 2024 Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.5768 YÖKSİS TR Index SJR Q3 JCR Q3

Akademisyenlere dön